Palatinal maxillary canine

K11_MAXIL_CANINE_PALAT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions K11_MAXIL_CANINE_OPER	377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K01, K07.35 Hospital discharge: ICD-10 — K01, K07.35 Cause of death: ICD-10 — K01, K07.35 3 out of 7 registries used, show all original rules.	305
4. Check minimum number of events None	305
5. Include endpoints None	305
6. Filter based on genotype QC (FinnGen only)	276

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_MAXIL_CANINE_PALAT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	K11_MAXIL_CANINE_OPER
OUTPAT_ICD	K0735\|K01
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K0735\|K01
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K0735\|K01
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Palatinal maxillary canine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8262	5033	3229
Only index persons	8021	4893	3128
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.09
Only index persons	0.16	0.18	0.12
Median age at first event (years)
Whole population	-	12.56	12.85
Only index persons	12.74	12.63	12.92

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	276	213	63
Unadjusted period prevalence (%)	0.06	0.08	0.03
Median age at first event (years)	13.35	13.18	13.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
288: Matched controls
2880

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ECA00

NOMESCO Finland

Surgical exposure of tooth

16384.0

307.7

286

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

92.6

197.4

106

K01.0

ICD-10 Finland

Embedded teeth

29.0

169.8

135

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

36.8

141.5

SJD00

NOMESCO Finland

Removal and/or reactivation of orthodontic arch wire

10.7

94.1

172

350

SJD10

NOMESCO Finland

Placement of orthodontic arch wire

10.6

93.2

173

358

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

10.4

91.6

162

316

SJC50

NOMESCO Finland

Removal of fixed orthodontic appliance with at least 7 brackets

7.8

67.9

143

322

SJD20

NOMESCO Finland

Placement of modified orthodontic arch wire

7.2

58.3

120

259

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

6.7

47.3

200

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

6.3

47.3

108

252

SBB10

NOMESCO Finland

Dental impressions

5.3

43.6

177

666

SJD30

NOMESCO Finland

Demanding placement of orthodontic arch wire

6.7

42.3

158

SJD40

NOMESCO Finland

Placement of prefabricated palatal or lingual arch

5.1

39.9

122

361

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

4.9

37.8

125

391

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

7.2

33.3

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

4.6

32.6

110

344

SJX10

NOMESCO Finland

Orthodontic treatment/control appointment, short

3.7

25.9

136

565

SJC10

NOMESCO Finland

Orthodontic band in one tooth

4.2

25.5

280

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

3.4

21.7

117

484

SXC05

NOMESCO Finland

Other oral or dental procedure

3.4

21.4

116

481

SAA04

NOMESCO Finland

Special examination of mouth

3.6

20.6

319

SJC40

NOMESCO Finland

Removal of fixed orthodontic appliance with at most 6 brackets

3.5

20.6

374

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

4.1

20.2

200

SAC01

NOMESCO Finland

Separate planning of oral and dental treatment, standard

3.4

16.6

256

EB1MA

NOMESCO Finland

Cephalometry with X-ray

3.3

16.4

287

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.0

16.3

204

1289

SJD50

NOMESCO Finland

Placement of prefabricated palatal or lingual arch, dentist-made

5.6

14.9

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

2.9

14.2

348

SJX20

NOMESCO Finland

Orthodontic treatment/control appointment

3.0

13.6

317

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.0

13.4

275

EBA00

NOMESCO Finland

Extraction of tooth

2.6

13.2

194

1269

WZA90

NOMESCO Finland

Other medical or dental certificate

2.5

13.2

137

763

OIKH, ,

NOMESCO Finland

2.8

12.5

317

EMAK, ,

NOMESCO Finland

5.7

12.5

OIKAL, ,

NOMESCO Finland

3.7

12.2

132

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.4

12.0

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.7

10.0

252

OIKK, ,

NOMESCO Finland

2.4

9.7

443

WX110

NOMESCO Finland

Infiltration anesthesia

3.5

9.6

261

2116

SJC00

NOMESCO Finland

Bondable bracket or other fixed attachement

15.7

9.6

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

103.3

9.5

K01.13

ICD-10 Finland

Retained canine with obstruction in the lower jaw

38.0

9.1

K01.1

ICD-10 Finland

Impacted teeth

8.3

8.5

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

2.8

8.4

183

K03.30

ICD-10 Finland

Internal granuloma of pulp

+∞

8.4

OIKRE, ,

NOMESCO Finland

4.6

7.8

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

2.9

7.4

134

SAA03

NOMESCO Finland

Extended examination of mouth

2.1

7.3

212

1636

K01.10

ICD-10 Finland

Retained front tooth with obstruction in the upper jaw

30.9

7.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

5.77

3.68

3.2

2.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

355

0.47

2.50

1.8

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.63

2.22

1.0

1.3

—

(3000492) Spirometry study

217

1.64

1.84

1.9

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2.71

1.73

2.1

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

648

0.67

1.72

5.3

3.7

62.61

49.16

e6/l

0.10

467

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.20

1.67

3.2

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

3.20

1.67

2.5

1.7

—

(3042733) HLA Ab [Presence] in Serum

3.04

1.59

4.5

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

592

0.68

1.55

4.8

3.7

0.10

0.21

e6/l

1.14

412

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.45

1.40

5.6

7.9

3.97

5.77

pmol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

136

1.67

1.37

26.1

16.2

1.23

1.05

mg/l

0.70

131

(40768441) Liver Pathology biopsy report

2.97

1.36

2.2

2.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.39

1.30

2.4

2.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.12

1.29

2.3

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.81

1.29

1.4

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.26

1.25

1.6

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

550

1.33

1.25

3.7

2.4

2.38

2.37

mmol/l

0.10

509

(3008898) HLA-B27 [Presence]

142

0.48

1.24

1.1

1.0

—

(3018095) Leukocytes [#/volume] in Urine

846

0.76

1.21

5.7

4.3

7.34

79.39

e6/l

3.38

515

(3000991) Gas panel - Venous blood

251

1.45

1.18

19.5

13.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.08

1.16

1.4

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

1.14

0.0

1.4

—

328.57

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.93

1.13

26.3

4.9

23.88

24.39

mmol/l

0.20

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.82

1.12

16.5

21.5

0.68

0.62

0.35

(3019150) Specific gravity of Urine by Refractometry

626

1.29

1.09

4.1

2.8

1.02

kg/l

0.10

369

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

378

0.68

1.07

5.3

3.1

0.50

0.98

e6/l

1.08

180

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

836

1.26

1.06

16.6

9.8

1.22

mmol/l

0.19

752

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

173

1.49

1.01

3.0

1.9

—

(44806118) Parainfluenza type 4 nucleic acid detection

2.02

1.00

4.6

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

2.02

1.00

4.6

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

2.02

1.00

4.6

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

2.02

1.00

4.6

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

338

0.68

0.99

1.5

1.2

1.19

7.28

u/ml

1.56

122

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

174

1.48

0.99

2.7

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.19

0.98

1.4

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

252

1.40

0.98

2.9

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

263

2704

0.68

0.94

19.6

14.9

134.07

134.67

g/l

0.33

257

2666

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

220

1.41

0.92

1.6

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

355

0.71

0.91

5.4

3.3

4.84

4.69

e6/l

0.02

158

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

104

0.47

0.91

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.09

0.90

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

376

0.72

0.89

1.7

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

876

0.81

0.85

2.5

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.95

0.85

3.2

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.78

0.84

1.8

12.00

19.51

ng/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

286

1.34

0.84

21.1

9.6

5.91

5.87

kpa

0.17

278

(3010421) pH of Blood

1.76

0.83

3.9

4.6

7.39

7.40

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.89

0.82

1.3

1.1

0.81

21.87

u/ml

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

214

2251

0.81

17.5

12.7

13.14

13.00

1.28

209

2223

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.75

0.80

3.8

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.79

0.0

3.7

—

105.82

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.84

0.79

3.0

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.69

0.79

1.0

1.7

—

(3012544) pH of Venous blood

289

1.32

0.79

21.3

9.6

7.39

7.36

2.01

194

(36660697) Celiac disease serology panel - Serum

362

1.29

0.78

1.4

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

668

0.80

0.77

4.8

3.9

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

2.9

—

5.19

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1.67

0.76

3.3

3.4

19.59

27.12

mu/l

0.36

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.72

0.76

4.0

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.63

0.76

18.1

20.9

22.75

23.68

mmol/l

0.39

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

117

1295

0.84

0.75

2.4

2.1

—

(3010813) Leukocytes [#/volume] in Blood

264

2703

0.72

0.73

19.3

14.7

6.73

6.80

e9/l

0.26

253

2623

(3020564) Creatinine [Moles/volume] in Serum or Plasma

224

2338

0.81

0.73

13.4

9.1

67.11

64.60

umol/l

0.73

219

2298

(40761511) CBC panel - Blood by Automated count

241

2496

0.79

0.73

10.4

7.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.02

0.73

3.6

1.6

—

(4198724) Urine methamphetamine measurement

1.81

0.73

1.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.60

0.73

17.8

20.8

96.88

95.74

1.28

(3023520) Reticulocytes [#/volume] in Blood

143

1.43

0.72

5.5

3.8

73.92

63.59

e9/l

0.49

103

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

264

2702

0.72

0.71

20.2

15.4

39.82

41.40

0.66

257

2665

(3026361) Erythrocytes [#/volume] in Blood

264

2702

0.72

0.71

19.3

14.7

4.54

4.59

e12/l

0.99

254

2626

(3035941) MCH [Entitic mass]

264

2702

0.72

0.71

19.2

14.7

29.67

29.49

1.11

258

2664

(3024731) MCV [Entitic mean volume] in Red Blood Cells

264

2702

0.72

0.71

19.2

14.7

88.46

87.90

1.48

258

2664

(3026782) Osmolality of Urine

383

0.76

0.71

2.8

3.2

607.56

592.29

mosm/kgh2o

0.10

342

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

517

1.23

0.69

2.7

75.89

56.99

u/l

0.40

473

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

221

2306

0.82

0.69

18.0

12.3

334.00

334.18

g/l

0.11

214

2284

(3011648) Oxygen content in Venous blood

1.87

0.68

13.2

25.5

10.70

12.40

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

242

1.31

0.68

14.6

10.0

24.10

23.52

mmol/l

0.68

242

(21494815) CD4 cells/Lymphocytes in Specimen

1.80

0.66

1.6

2.5

39.50

39.48

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

101

903

1.18

0.66

4.6

2.9

0.00

0.02

estimate

0.68

225

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.63

0.66

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

177

0.66

0.65

1.2

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

177

0.66

0.65

1.2

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1.50

0.65

3.1

3.2

85.63

95.15

ml/min/173m2

—

(3007461) Platelets [#/volume] in Blood

264

2698

0.74

0.64

19.3

14.8

269.31

266.73

e9/l

0.28

255

2625

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.54

0.63

2.0

—

(3024928) Oxygen saturation in Venous blood

1.62

0.62

9.9

17.1

73.46

64.87

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1.68

0.61

2.2

1.2

13.20

12.91

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

219

1.31

0.61

1.3

403.93

251.06

miu/ml

0.92

112

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.58

0.61

1.4

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.60

0.0

1.1

—

8.60

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.60

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.60

0.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.55

0.60

1.1

1.7

8.59

6.91

mmol/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

2.2

—

6.35

—

(3041096) Erythrocytes [Presence] in Urine by Automated

718

1.18

0.58

3.8

2.6

0.00

0.01

estimate

0.50

231

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.73

0.58

1.0

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.73

0.58

2.0

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.73

0.58

1.0

1.2

—

(42870588) Differential panel, method unspecified - Blood

825

1.17

0.57

12.1

7.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

203

2122

0.85

0.57

16.0

9.8

3.88

3.86

mmol/l

0.47

189

2054

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.56

0.56

2.5

2.2

—

(1616796) Gas panel - Central venous blood

1.63

0.56

3.7

6.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.48

0.55

8.7

12.3

0.58

0.62

0.24

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

224

2321

0.84

0.54

10.1

7.8

22.23

23.74

u/l

0.89

212

2244

(3019550) Sodium [Moles/volume] in Serum or Plasma

204

2129

0.86

0.54

15.8

9.8

139.38

139.47

mmol/l

0.31

189

2068

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

247

0.75

0.53

1.2

1.4

2.47

3.13

mmol/l

1.88

148

(3024354) Oxygen [Partial pressure] in Venous blood

270

1.25

0.53

16.2

9.1

5.23

4.92

kpa

0.38

263

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

261

1.25

0.52

17.9

15.1

24.87

24.85

mmol/l

0.01

261

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

109

1185

0.87

0.51

2.8

2.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

776

0.85

0.51

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

155

0.70

0.50

1.6

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.53

0.48

1.1

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

527

1.17

0.48

1.9

1.7

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

169

1780

0.88

0.48

8.0

6.7

108.74

111.72

ml/min/173m2

0.86

127

1422

(3022621) pH of Urine by Test strip

173

1.29

0.48

1.7

1.9

6.31

6.34

0.06

112

(3014576) Chloride [Moles/volume] in Serum or Plasma

173

1.29

0.48

14.9

14.1

105.91

105.47

mmol/l

0.32

173

(3009214) Lutropin [Units/volume] in Serum or Plasma

232

0.76

0.48

1.9

2.0

40.05

6.70

u/l

—

177

(3019230) Fractional oxyhemoglobin in Venous blood

1.50

0.48

10.1

17.3

70.57

66.38

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

158

1489

1.14

0.47

2.8

3.1

33.93

35.20

mmol/mol

1.82

149

1411

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

120

1.35

0.47

1.2

1.4

—

(3000494) Fungus identified in Specimen by Culture

210

1.26

0.47

1.6

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

361

0.81

0.46

1.3

1.2

8.17

16.10

iu/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.44

0.46

1.4

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

1.44

0.46

1.3

2.4

—

(3015736) pH of Urine

109

1005

1.14

0.46

4.4

2.9

6.59

6.37

1.38

500

(3013650) Neutrophils [#/volume] in Blood by Automated count

131

1398

0.88

0.45

12.8

8.2

3.71

3.78

e9/l

0.14

108

1206

(3029937) Albumin [Presence] in Urine by Test strip

636

1.15

0.45

5.0

3.3

0.00

0.01

estimate

0.80

263

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

130

1.33

0.45

2.6

2.2

—

(40758558) Short blood count panel - Blood

705

0.86

0.44

9.4

5.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

131

0.68

0.44

1.1

1.5

2.77

3.72

ug/l

—

122

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

104

1.36

0.44

2.4

1.9

—

(3002030) Lymphocytes/Leukocytes in Blood

117

1255

0.89

0.43

11.7

7.1

31.89

32.55

0.30

111

1206

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

215

2223

0.87

0.43

4.9

4.7

1.73

1.81

mu/l

0.59

205

2119

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

304

0.81

0.43

1.2

1.4

2.83

3.31

ratio

1.42

195

(40760892) CBC W Ordered Manual Differential panel - Blood

620

0.86

0.42

5.5

4.4

—

(44813793) Dust mix specific IgE antibody measurement

1.57

0.42

1.2

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

431

0.84

0.42

3.1

3.0

8.91

12.26

e6/l

0.72

386

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.39

0.42

1.6

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.52

0.41

3.2

1.7

—

(3019198) Lymphocytes [#/volume] in Blood

124

1322

0.89

0.41

11.5

7.1

2.06

2.05

e9/l

0.03

108

1180

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.37

0.41

1.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

3.4

—

1.81

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.41

0.0

1.2

—

(3021589) Normoblasts [#/volume] in Blood

112

1200

0.89

0.40

12.7

8.9

0.00

e9/l

0.50

963

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

0.68

0.40

1.6

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.32

0.40

1.9

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1.42

0.39

1.0

1.1

0.90

4.17

eliau/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

115

1.32

0.39

1.8

2.0

—

(4062490) Immunoglobulin typing, IgG

1.40

0.38

1.6

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

152

1.27

0.38

1.4

1.6

1213.83

997.91

nmol/l

0.35

120

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

320

1.18

0.37

1.1

1.0

—

(3044889) 12 lead EKG panel

106

1132

0.90

0.35

2.4

2.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

149

1563

0.90

0.35

4.0

4.1

6.92

7.12

mm/h

0.13

142

1455

(3019977) pH of Arterial blood

109

1.30

0.34

15.9

20.0

7.41

—

(3028707) Methadone [Presence] in Urine by Screen method

220

0.81

0.34

2.5

2.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.67

0.33

1.0

1.40

1.52

g/l

—

(3000330) Specific gravity of Urine by Test strip

0.66

0.33

2.7

1.8

1.02

ratio

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

251

0.82

0.32

1.2

1.6

69.10

63.64

ug/l

0.17

225

(3044640) Blood type and Crossmatch panel - Blood

652

1.12

0.32

3.3

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

106

1126

0.91

0.31

2.5

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

324

0.85

0.31

1.5

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

175

1.22

0.31

2.5

4.8

281.07

516.16

ng/l

0.77

134

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

239

0.82

0.31

1.7

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

222

1.19

0.30

5.4

3.1

18.92

23.59

1.19

210

(1002224) Polysomnography panel

1.30

0.30

1.0

1.1

—

(40761535) Cells panel - Urine sediment

102

1.29

0.30

4.4

3.0

—

(4024509) Urine culture

102

1.29

0.30

1.8

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

102

1.29

0.30

3.4

2.3

0.09

0.18

e6/l

0.47

(3003327) Ova and parasites identified in Stool by Light microscopy

152

0.78

0.30

1.6

1.7

—

(3018418) pH of Serum or Plasma

442

1.13

0.29

9.3

3.5

7.39

0.09

303

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

240

2447

0.88

0.29

4.3

4.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

140

0.78

0.29

1.1

1.2

—

38.26

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.30

0.28

2.5

2.7

—

19.86

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

669

1.10

0.26

1.4

1.6

97.05

96.09

pmol/l

0.07

358

(3013115) Eosinophils [#/volume] in Blood

125

1309

0.92

0.26

12.2

7.5

0.18

e9/l

0.27

107

1152

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

506

0.89

0.26

1.4

1.6

1018.19

952.33

mu/l

0.21

465

(3050129) First trimester maternal screen panel - Serum or Plasma

331

1.14

0.25

1.6

1.4

—

(40768804) Tissue Pathology biopsy report

573

1.10

0.25

2.0

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

170

1.19

0.25

1.6

2.0

—

(3013512) EKG study

349

0.87

0.25

1.8

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1004

0.92

0.25

3.5

3.0

—

estimate

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

163

1574

1.08

0.25

3.6

3.3

48.14

45.61

ug/l

0.18

157

1494

(3035350) Ketones [Presence] in Urine by Test strip

128

1226

1.08

0.24

5.0

3.3

0.00

5.69

estimate

0.50

265

(3019832) Treponema pallidum Ab [Presence] in Serum

100

949

1.08

0.23

1.9

2.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

221

0.85

0.23

1.3

1.5

1.24

1.16

ratio

0.11

137

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

221

0.85

0.23

1.3

1.5

1.11

1.24

ratio

0.26

137

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

221

0.85

0.23

1.3

1.5

0.92

ratio

0.02

137

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

167

1722

0.93

0.23

2.9

2.8

4.31

4.41

mmol/l

0.78

161

1650

(3009261) Glucose [Presence] in Urine by Test strip

128

1229

1.07

0.22

5.0

3.4

0.00

estimate

-0.00

262

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.21

0.0

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.21

0.0

1.5

—

(3036603) Volume of Urine

0.00

0.21

0.0

1.5

—

1624.09

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

56.00

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(21494434) Karyotype in Bone marrow

0.00

0.21

0.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

19.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

927

0.93

0.21

2.1

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

134

0.81

0.21

3.0

2.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

47.44

—

(4035726) Immunohistochemistry procedure

1.26

0.20

1.6

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.20

0.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

144

0.83

0.20

1.8

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

289

1.12

0.20

4.5

2.8

13.53

14.85

umol/l

0.50

270

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

122

0.81

0.19

1.7

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

126

1214

1.07

0.19

5.0

3.3

0.00

estimate

-0.00

273

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.16

0.19

1.3

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

801

0.93

0.18

9.2

5.7

9.85

10.50

umol/l

0.33

741

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

119

1.19

0.18

3.1

1.7

—

(3022145) Colonoscopy Study observation

142

0.84

0.18

1.9

1.4

—

(3001604) Monocytes [#/volume] in Blood

122

1263

0.94

0.17

11.6

7.3

0.52

e9/l

0.02

103

1095

(3013826) Glucose [Moles/volume] in Serum or Plasma

116

1118

1.06

0.17

9.3

6.5

5.80

5.97

mmol/l

0.57

102

981

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.74

0.17

1.0

1.6

—

(3006315) Basophils [#/volume] in Blood

122

1262

0.94

0.17

11.6

7.3

0.04

e9/l

0.06

104

1095

(3011288) Drugs identified in Urine by Screen method Nominal

339

0.90

0.17

1.6

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

132

1361

0.94

0.16

7.9

5.6

85.60

84.40

u/l

0.09

125

1274

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

214

0.88

0.16

1.3

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.13

0.16

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.13

0.16

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

172

0.87

0.16

1.9

1.4

—

47.38

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

501

0.93

0.15

3.6

2.5

—

(1761868) Lipid panel - Serum or Plasma

736

1.06

0.15

1.7

1.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.78

0.14

1.0

0.80

0.81

g/l

—

(3022313) Gas panel - Capillary blood

189

1.12

0.14

10.6

7.2

—

(40761536) Microorganisms panel - Urine sediment

222

0.89

0.14

4.3

3.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

149

0.87

0.14

1.6

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

109

1055

1.05

0.14

1.6

1.7

1.22

2.47

u/ml

0.97

238

(3001019) Free T4 and TSH panel - Serum or Plasma

0.80

0.14

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

248

1.10

0.13

1.6

1.7

—

(3006504) Eosinophils/Leukocytes in Blood

115

1182

0.95

0.12

11.8

7.4

2.81

0.01

107

1120

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

485

0.94

0.11

2.3

2.5

3405.84

6049.49

u/l

0.51

173

(3017181) Myelocytes/Leukocytes in Blood

153

1.12

0.11

3.6

5.7

0.20

0.93

—

(3002256) Pathology report gross observation

187

0.90

0.10

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

271

1.08

0.10

1.8

1.5

—

(3012516) Albumin [Mass/volume] in Urine

232

1.08

0.10

4.0

4.5

95.38

99.85

mg/l

0.03

192

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

167

1698

0.96

0.10

2.8

2.7

1.42

1.43

mmol/l

0.10

159

1619

(46235355) HIV 1 and 2 tests - Meaningful Use set

122

1248

0.96

0.10

2.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

389

1.06

0.10

2.0

6.57

13.01

ng/l

—

102

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

262

1.08

0.09

1.9

2.8

386.73

818.59

ng/l

0.85

101

(3025941) Bacteria identified in Stool by Culture

145

1.11

0.09

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

461

0.95

0.09

2.0

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

168

1706

0.96

0.09

2.9

2.7

2.55

2.64

mmol/l

0.85

160

1630

(3032080) INR in Blood by Coagulation assay

521

0.95

0.09

4.4

4.3

1.05

inr

0.04

445

(3048689) Calprotectin [Mass/mass] in Stool

541

0.95

0.08

2.1

3.0

140.60

73.86

ug/g

0.43

412

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

185

0.91

0.08

12.4

7.0

23.42

24.35

mmol/l

0.46

185

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.78

0.08

1.2

—

27.29

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

117

1.12

0.08

1.2

—

6.29

—

(40768443) Skin Pathology biopsy report

1.06

0.08

1.3

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

284

1.06

0.07

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.80

0.07

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.84

0.07

1.3

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

199

2010

0.97

0.07

4.2

3.9

14.40

14.35

pmol/l

0.11

180

1783

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

102

0.88

0.06

1.1

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

414

1.05

0.06

3.8

2.8

2.98

0.96

mg/l

0.42

262

(3023368) Bacteria identified in Blood by Culture

355

1.05

0.06

5.6

3.8

—

(21494755) Public health laboratory ask at order entry panel

213

0.93

0.06

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

294

0.95

0.06

1.4

1.3

156.76

119.27

u/ml

—

105

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

179

1771

1.03

0.06

2.7

2.5

5.14

5.33

mmol/l

4.07

170

1621

(1001926) Buprenorphine [Presence] in Urine by Screen method

405

1.04

0.06

1.9

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

141

0.92

0.05

1.3

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

239

2405

0.96

0.05

12.5

9.9

21.42

21.36

mg/l

0.01

184

1783

(3019069) Monocytes/Leukocytes in Blood

117

1188

0.97

0.05

11.6

7.4

8.32

8.26

0.10

108

1129

(3023323) Follitropin [Units/volume] in Serum or Plasma

208

1.06

0.05

1.7

2.0

23.41

7.37

iu/l

0.42

160

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

100

1.10

0.05

4.5

3.7

1.23

mmol/l

0.07

(3000764) Benzodiazepines [Presence] in Urine

494

0.97

0.05

1.9

1.8

—

(3022096) Basophils/Leukocytes in Blood

116

1176

0.98

0.04

11.7

7.4

0.59

0.62

0.25

108

1119

(3042936) Bacteria identified in Isolate by Culture

219

1.05

0.04

2.0

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

498

1.03

0.03

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

102

1.08

0.03

1.6

1.7

—

5.07

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

103

1.07

0.02

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

137

0.95

0.01

1.5

1.3

—

(3028300) Cannabinoids [Presence] in Urine

498

0.98

0.01

1.9

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

914

1.01

0.00

1.6

1.72

1.74

g/l

0.05

560

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

218

1.01

0.00

1.5

1.6

52.65

55.09

ug/l

0.12

218

(3027944) Amphetamines [Presence] in Urine

492

1.00

0.00

1.9

1.8

—

(40768797) Stomach Pathology biopsy report

181

0.99

0.00

1.4

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

259

1.00

0.00

1.6

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

143

1434

0.99

0.00

4.9

3.6

27.98

24.39

u/l

0.28

136

1373

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

639

1.00

0.00

1.5

1.8

1.26

1.18

mmol/l

0.43

585

(3028626) Oxygen [Partial pressure] in Capillary blood

183

0.98

0.00

11.8

6.9

10.28

9.94

kpa

0.33

176

(3026008) Bacteria identified in Urine by Culture

703

0.99

0.00

3.4

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

225

1.02

0.00

11.5

6.9

1.32

0.93

mmol/l

0.31

156

(3027008) Opiates [Presence] in Urine

495

0.99

0.00

1.9

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

126

1.03

0.00

9.5

5.2

144.15

177.72

0.86

120

(3019225) pH of Specimen

114

0.96

0.00

1.2

4.1

7.38

7.32

—

(3003694) ABO and Rh group [Type] in Blood

101

1007

1.00

0.00

1.7

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

155

1552

1.00

0.00

6.1

4.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.00

0.00

1.1

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

-0.00

0.0

2.2

—

1.20

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

3.4

—

9.20

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.1

—

6.17

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

25.20

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

7.6

—

4.91

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.92

-0.00

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

4.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

32.00

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.91

-0.00

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.94

-0.00

1.8

1.5

0.40

0.53

e9/l

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

17.91

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

-0.00

0.0

1.0

—

19.00

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

58.32

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

30.2

—

0.61

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

0.88

-0.00

1.4

1.8

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

2.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.90

-0.00

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

2.2

—

103.00

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

10.17

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.87

-0.00

1.2

—

2.55

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3049717) Cytology report of Urine Cyto stain

0.00

-0.00

0.0

1.3

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

38.00

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

4.8

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

4.44

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

-0.00

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.02

-0.00

1.2

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.6

—

81.36

—

(3006270) Folate [Moles/volume] in Blood

0.00

-0.00

0.0

1.1

—

402.57

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MAXIL_CANINE_PALAT and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MAXIL_CANINE_PALAT.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: K11_MAXIL_CANINE_PALAT – Palatinal maxillary canine

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Palatinal maxillary canine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints